Clinical Trials

Winship Cancer Institute is dedicated to educating cancer patients and their families about standard cancer treatments and new treatments that are available. A cancer clinical trial is an important option to consider when deciding a course of action.

dr waller news image

Our participation in national, international and institutional clinical trials assures that we offer patients the newest knowledge in stem cell biology and transplant immunology.

We also collaborate in research and clinical and basic science through a number of national and international organizations.

• National Bone Marrow Donor Program Affiliate

• Fred Hutchinson Research Collaborative for Nonmyeloablative Transplant Consortium

• Multiple Myeloma Research Foundation Affiliate (MMRF)

• Eastern Cooperative Oncology Group (ECOG)

• Center for International Blood and Marrow Transplant Research (CIBMTR)

Cancer clinical trials are research studies that test new treatments to find better ways to treat cancer. There are three types of clinical trials.

Phase I Clinical Trial

A Phase I trial tests a brand new drug, device or procedure. This type of trial does not look for the medical benefits; it only looks for how well humans handle the new drug or procedure.  Phase I trials are run to see which dose, or how much of the drug works best.

Phase II Clinical Trial

Phase II trials test the drug to see if it works against a specific disease (like prostate cancer). In these research studies, the researchers record the medical benefits they find.

Phase III Clinical Trial

In Phase III trials, the new drug or procedure is compared to accepted standard treatment to find out which works best.

BMT Clinical Trials by Disease

Hematological Cancers

Multiple Myeloma



Testicular cancer

National awards & recognition


• Winship is a National Cancer Institute - Designated Cancer Center
• US News & World Report “America’s Best Hospitals"
• Accredited by the American College of Surgeons Commission on Cancer
• Joint Commission on Accreditation of Healthcare Organizations
• Blue Cross Distinction - Center for Complex and Rare Cancers
• OptumHealth Center of Excellence for Bone Marrow Transplant
• Foundation for the Accreditation of Cell Therapy (FACT) Accredited
• Center of Excellence of the Myelodysplastic Syndromes Foundation.